Companies: 10,795·Total market cap: $144.5T
CalciMedica, Inc.

CalciMedica, Inc.

CALCNASDAQHealthcare● Active
$0.94
$-0.01(-1.41%)
Market Cap$14921240
P/E Ratio
52W High$7.2
52W Low$0.461

CalciMedica, Inc. (CALC) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · CALC · as of Jun 9, 2026

Activity summary

Buy transactions

29

P-Purchase only

Sell transactions

1

12 Months

Buy/Sell ratio

29.00

Buy/Sell (by trades)

Overall sentiment

BULLISH
↑ Buy 97%Active transactions only · RSU vesting excluded3% Sell ↓

CalciMedica, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

CALC insider buying and selling by quarter

CALC insider selling · CALC insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
3.7M1.8M0
2025 Q1
2025 Q2
2025 Q3
2025 Q4

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Active insiders

Most active in past 12 months · CALC ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

CALC executive sell shares · CALC board member insider trading · CALC insider trading SEC filing

Showing 43 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Roberts Eric W

CHIEF BUSINESS OFFICER · Director

Purchase

Date

Sep 18

Shares

2,500

Price

$3.07

Value

$8K

View Form 4 on SEC.gov

Roberts Eric W

CHIEF BUSINESS OFFICER · Director

Purchase

Date

Sep 15

Shares

3,400

Price

$2.68

Value

$9K

View Form 4 on SEC.gov

Roberts Eric W

CHIEF BUSINESS OFFICER · Director

Purchase

Date

Sep 12

Shares

5,000

Price

$3.12

Value

$16K

View Form 4 on SEC.gov

Roberts Eric W

CHIEF BUSINESS OFFICER · Director

Purchase

Date

Sep 9

Shares

2,343

Price

$3.15

Value

$7K

View Form 4 on SEC.gov

Roberts Eric W

CHIEF BUSINESS OFFICER · Director

Purchase

Date

Aug 29

Shares

800

Price

$2.74

Value

$2K

View Form 4 on SEC.gov

Roberts Eric W

CHIEF BUSINESS OFFICER · Director

Purchase

Date

Aug 28

Shares

9,200

Price

$2.86

Value

$26K

View Form 4 on SEC.gov

Roberts Eric W

CHIEF BUSINESS OFFICER · Director

Purchase

Date

Aug 21

Shares

3,508

Price

$2.79

Value

$10K

View Form 4 on SEC.gov

Roberts Eric W

CHIEF BUSINESS OFFICER · Director

Option

Date

Aug 20

Shares

15,000

Price

$1.53

Value

$23K

View Form 4 on SEC.gov

Roberts Eric W

CHIEF BUSINESS OFFICER · Director

Purchase

Date

Aug 20

Shares

2,000

Price

$2.72

Value

$5K

View Form 4 on SEC.gov

Roberts Eric W

CHIEF BUSINESS OFFICER · Director

Purchase

Date

Aug 19

Shares

1,000

Price

$2.79

Value

$3K

View Form 4 on SEC.gov

Hebbar Sudarshan

Chief Medical Officer

Purchase

Date

Aug 19

Shares

9,563

Price

$2.82

Value

$27K

View Form 4 on SEC.gov

Roberts Eric W

CHIEF BUSINESS OFFICER · Director

Purchase

Date

Aug 15

Shares

5,076

Price

$2.90

Value

$15K

View Form 4 on SEC.gov

Hebbar Sudarshan

Chief Medical Officer

Purchase

Date

Aug 15

Shares

4,392

Price

$2.79

Value

$12K

View Form 4 on SEC.gov

Hebbar Sudarshan

Chief Medical Officer

Purchase

Date

Aug 14

Shares

1,584

Price

$2.58

Value

$4K

View Form 4 on SEC.gov

Stauderman Kenneth A.

Chief Scientific Officer

Purchase

Date

Jul 28

Shares

1,000

Price

$3.96

Value

$4K

View Form 4 on SEC.gov

Stauderman Kenneth A.

Chief Scientific Officer

Sale

Date

Jul 25

Shares

1,000

Price

$3.65

Value

$4K

View Form 4 on SEC.gov

Roberts Eric W

CHIEF BUSINESS OFFICER · Director

Purchase

Date

Jul 22

Shares

1,500

Price

$3.77

Value

$6K

View Form 4 on SEC.gov

Roberts Eric W

CHIEF BUSINESS OFFICER · Director

Purchase

Date

Jul 21

Shares

1,500

Price

$3.37

Value

$5K

View Form 4 on SEC.gov

Leheny A. Rachel

CHIEF EXECUTIVE OFFICER · Director

Purchase

Date

Jul 21

Shares

1,000

Price

$3.40

Value

$3K

View Form 4 on SEC.gov

WILSON ROBERT N

Director

Purchase

Date

Jul 18

Shares

4,500

Price

$2.87

Value

$13K

View Form 4 on SEC.gov

Roberts Eric W

CHIEF BUSINESS OFFICER · Director

Purchase

Date

Jul 18

Shares

2,000

Price

$2.88

Value

$6K

View Form 4 on SEC.gov

Roberts Eric W

CHIEF BUSINESS OFFICER · Director

Purchase

Date

Jul 14

Shares

6,500

Price

$2.43

Value

$16K

View Form 4 on SEC.gov

Leheny A. Rachel

CHIEF EXECUTIVE OFFICER · Director

Purchase

Date

Jul 14

Shares

2,500

Price

$2.47

Value

$6K

View Form 4 on SEC.gov

Roberts Eric W

CHIEF BUSINESS OFFICER · Director

Purchase

Date

Jul 9

Shares

5,000

Price

$1.60

Value

$8K

View Form 4 on SEC.gov

Stauderman Kenneth A.

Chief Scientific Officer

Purchase

Date

Jul 1

Shares

1,000

Price

$1.85

Value

$2K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 2

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About CALC insider trading

CALC insider trades

CalciMedica, Inc. (CALC) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Roberts Eric W (CHIEF BUSINESS OFFICER · Director), Hebbar Sudarshan (Chief Medical Officer), Stauderman Kenneth A. (Chief Scientific Officer). Over the past 12 months, 5 insiders have filed transactions with the SEC. CALC insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For CalciMedica, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

CALC insider trading · 5 questions

The insiders of CalciMedica, Inc. (CALC) include executives and directors such as Roberts Eric W (CHIEF BUSINESS OFFICER · Director), Hebbar Sudarshan (Chief Medical Officer), Stauderman Kenneth A. (Chief Scientific Officer), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

CALC board member insider tradingwho are CALC insidersCALC insider rosterCalciMedica, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026